SYNTA PHARMACEUTICALS CORP's ticker is SNTA and the CUSIP is 87162T206. A total of 54 filers reported holding SYNTA PHARMACEUTICALS CORP in Q2 2016. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $0 | – | 2,850 | 0.0% | 0.00% | – |
| Q1 2016 | $0 | -100.0% | 2,850 | +54.1% | 0.00% | – |
| Q4 2015 | $1,000 | 0.0% | 1,850 | +428.6% | 0.00% | – |
| Q3 2015 | $1,000 | 0.0% | 350 | 0.0% | 0.00% | – |
| Q2 2015 | $1,000 | -80.0% | 350 | -85.1% | 0.00% | – |
| Q1 2015 | $5,000 | 0.0% | 2,350 | +17.5% | 0.00% | – |
| Q4 2014 | $5,000 | -16.7% | 2,000 | -2.5% | 0.00% | – |
| Q3 2014 | $6,000 | -25.0% | 2,052 | 0.0% | 0.00% | – |
| Q2 2014 | $8,000 | -11.1% | 2,052 | +2.6% | 0.00% | – |
| Q1 2014 | $9,000 | -10.0% | 2,000 | 0.0% | 0.00% | – |
| Q4 2013 | $10,000 | -60.0% | 2,000 | -50.0% | 0.00% | -100.0% |
| Q3 2013 | $25,000 | – | 4,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CAXTON CORP | 21,704,847 | $5,209,000 | 7.19% |
| CAXTON CORP | 67,000 | $16,000 | 0.02% |
| McQueen, Ball & Associates Inc. | 102,742 | $25,000 | 0.02% |
| TWO SIGMA SECURITIES, LLC | 36,056 | $9,000 | 0.01% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 1,398,330 | $336,000 | 0.01% |
| WEDBUSH SECURITIES INC | 45,000 | $11,000 | 0.00% |
| Roundview Capital LLC | 21,100 | $5,000 | 0.00% |
| Renaissance Technologies | 2,332,995 | $560,000 | 0.00% |
| PANAGORA ASSET MANAGEMENT INC | 618,599 | $148,000 | 0.00% |
| Virtu KCG Holdings LLC | 107,071 | $26,000 | 0.00% |